ATE172305T1 - Immunologisches verfahren zum nachweis von glykosaminoglykan-aktiviertem antithrombin iii; die entsprechenden monoklonalen antikörper und deren herstellung - Google Patents

Immunologisches verfahren zum nachweis von glykosaminoglykan-aktiviertem antithrombin iii; die entsprechenden monoklonalen antikörper und deren herstellung

Info

Publication number
ATE172305T1
ATE172305T1 AT95916732T AT95916732T ATE172305T1 AT E172305 T1 ATE172305 T1 AT E172305T1 AT 95916732 T AT95916732 T AT 95916732T AT 95916732 T AT95916732 T AT 95916732T AT E172305 T1 ATE172305 T1 AT E172305T1
Authority
AT
Austria
Prior art keywords
iii
agent
activated
pct
production
Prior art date
Application number
AT95916732T
Other languages
English (en)
Inventor
Jean-Claude Lormeau
Blandine Georgette Renee Mille
Francis Egiste Joseph Paolucci
Bernard Pau
Original Assignee
Pasteur Sanofi Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Sanofi Diagnostics filed Critical Pasteur Sanofi Diagnostics
Application granted granted Critical
Publication of ATE172305T1 publication Critical patent/ATE172305T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8128—Antithrombin III

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95916732T 1994-04-14 1995-04-10 Immunologisches verfahren zum nachweis von glykosaminoglykan-aktiviertem antithrombin iii; die entsprechenden monoklonalen antikörper und deren herstellung ATE172305T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404469A FR2718849B1 (fr) 1994-04-14 1994-04-14 Procédé d'immunodosage de l'antithrombine III activée par un glycosaminoglycane, anticorps monoclonaux correspondants et leur procédé d'obtention.

Publications (1)

Publication Number Publication Date
ATE172305T1 true ATE172305T1 (de) 1998-10-15

Family

ID=9462114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95916732T ATE172305T1 (de) 1994-04-14 1995-04-10 Immunologisches verfahren zum nachweis von glykosaminoglykan-aktiviertem antithrombin iii; die entsprechenden monoklonalen antikörper und deren herstellung

Country Status (9)

Country Link
US (1) US5891647A (de)
EP (1) EP0755518B1 (de)
AT (1) ATE172305T1 (de)
AU (1) AU2311595A (de)
CA (1) CA2187670A1 (de)
DE (1) DE69505365T2 (de)
ES (1) ES2125011T3 (de)
FR (1) FR2718849B1 (de)
WO (1) WO1995028644A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU782661B2 (en) * 1999-06-30 2005-08-18 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
US20040038932A1 (en) * 2000-09-08 2004-02-26 Jack Hirsh Antithrombotic compositions
DE10239821A1 (de) * 2002-08-29 2004-03-11 Roche Diagnostics Gmbh Verbesserung der Spezifität bei der Bestimmung von Antithrombin
US8617820B2 (en) * 2007-08-28 2013-12-31 Ortho-Clinical Diagnostics, Inc. Use of glycosaminoglycans to reduce non-specific binding in immunoassays
WO2011005818A1 (en) * 2009-07-08 2011-01-13 Bio-Rad Laboratories, Inc. Purification of monoclonal antibodies
EP2970500A1 (de) 2013-03-14 2016-01-20 Bayer HealthCare LLC Monoklonale antikörper gegen mit heparin komplexiertes beta-antithrombin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7602423A (nl) * 1976-03-08 1977-09-12 Leuven Res & Dev Vzw Bepaling van heparine in bloedplasma.
DE2804590A1 (de) 1978-02-03 1979-08-09 Licentia Gmbh Schalteranordnung zur stummschaltung in einem rundfunkempfaenger
FR2564468B1 (fr) * 1984-05-16 1994-12-23 Choay Sa Nouveaux oligosaccharides, leur preparation par voie de synthese et leurs applications biologiques
FR2535306A1 (fr) * 1982-10-28 1984-05-04 Martinez Antoine Procede de synthese organique d'oligosaccharides correspondant a des fragments de muco-polysaccharides naturels, nouveaux oligosaccharides obtenus et leurs applications biologiques
BE896543A (fr) * 1983-04-22 1983-08-16 Wallone Region Ensembles d'anticorps monoclonaux deriges contre les proteines humaines impliquees dans la coagulation et la fibrinolyse du sang
DE3804590A1 (de) * 1987-02-25 1988-09-08 Miles Inc Diagnostische sonden zum nachweis von elastase-modifiziertem antithrombin und verfahren zur behandlung
EP0341927B1 (de) * 1988-05-10 1993-07-14 AMERSHAM INTERNATIONAL plc Biosensoren
FR2645647B1 (fr) * 1989-04-07 1991-07-05 Stago Diagnostica Procede de dosage de complexes antithrombine-proteases
JPH0694713A (ja) * 1991-07-31 1994-04-08 Masashi Funayama アンチトロンビンｉｉｉ活性の測定方法とそれを用いたアンチトロンビンｉｉｉ活性の測定キット

Also Published As

Publication number Publication date
AU2311595A (en) 1995-11-10
WO1995028644A1 (fr) 1995-10-26
EP0755518B1 (de) 1998-10-14
DE69505365D1 (de) 1998-11-19
FR2718849B1 (fr) 1996-06-14
CA2187670A1 (fr) 1995-10-26
DE69505365T2 (de) 1999-05-06
US5891647A (en) 1999-04-06
FR2718849A1 (fr) 1995-10-20
ES2125011T3 (es) 1999-02-16
EP0755518A1 (de) 1997-01-29

Similar Documents

Publication Publication Date Title
Mallinson et al. Identification and partial characterization of the human erythrocyte membrane component (s) that express the antigens of the LW blood-group system
Furthmayr Immunization procedures, isolation by affinity chromatography, and serological and immunochemical characterization of collagen specific antibodies
FI964845A (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
DE69133179T2 (de) Katalytische antikörperkomponente
DE69934697T2 (de) Verfahren zur detektion von legionella bakterien unter verwendung aufgereinigter antigen-spezifischer antikörper
Veerman et al. Binding of human high-molecular-weight salivary mucins (MG1) to Hemophilus parainfluenzae
DE59008810D1 (de) Verfahren zum nachweis von malignen erkrankungen.
DE69505365D1 (de) Immunologisches verfahren zum nachweis von glykosaminoglykan-aktiviertem antithrombin iii; die entsprechenden monoklonalen antikörper und deren herstellung
DE59509344D1 (de) Antikörperklassenspezifisches entstörungsreagenz
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
DE69018968T2 (de) BLUTGERINNUNGSFAKTOR BETA XIIa MONOKLONALE ANTIKÖRPER UND IMMUNANALYSE.
DE69934250D1 (de) Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp
KR930008463A (ko) 치주 질환과 연관된 미생물들을 검증하기 위한 세정 조성물, 시험키트 및 방법
DE69529106D1 (de) Monoklonaler Antikörper gegen denThrombin-Antithrombin III-Komplex und dessen Verwendung in Immunoassays
FI973418A0 (fi) Vasta-ainetuotannon toteaminen
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
DE69426383D1 (de) Verfahren zur Bestimmung vom rheumatoiden Faktor und Kit dazu
ATE110853T1 (de) Immuntestverfahren für zelluläres eiweiss.
KR950031110A (ko) 인간 혈증 아포지단백질 비-100(b-100)에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주
MAENO et al. Characteristics of a 28-kDa collagenous protein extracted with guanidine from EDTA-demineralized rabbit alveolar bone
KR960006941A (ko) 인간 혈중 아포지단백질(apolipoprotein) A-I에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주
KR890015752A (ko) 항-cpbii 모노클로날 항체

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties